| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016555 |
| Receipt No. | R000019212 |
| Official scientific title of the study | A retrospective cohort study to evaluate the accuracy of preoperative risk classification of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration biopsy using a 19 gauge needle |
| Date of disclosure of the study information | 2015/02/20 |
| Last modified on | 2016/05/12 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A retrospective cohort study to evaluate the accuracy of preoperative risk classification of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration biopsy using a 19 gauge needle | |
| Title of the study (Brief title) | Preoperative risk classification of GIST by EUS-FNA | |
| Region |
|
|
| Condition | ||
| Condition | GIST | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the accuracy of preoperative risk classification of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration biopsy using a 19 gauge needle |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Co-efficiency of the recurrence risk classification of GIST between EUS-FNA samples and resected specimens |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with submucosal lesion of stomach which was judged we can perform EUS-FNA | |||
| Key exclusion criteria | 1)Age below 20 years
2) Patients with bleeding tendency 3) Patients whose informed consent could not be obtained. 4)In case that doctors judged inappropriate for the entry |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Ichiro Yasuda |
| Organization | Teikyo University Mizonokuchi Hospital |
| Division name | Department of Gastroenterology |
| Address | 3-8-3 Mizonokuchi, Takatsu-ku, Kawasaki, 213-8507, Japan |
| TEL | +81-44-844-3333 |
| YASUDAIC@aol.com | |
| Public contact | |
| Name of contact person | Ichiro Yasuda |
| Organization | Teikyo University Mizonokuchi Hospital |
| Division name | Department of Gastroenterology |
| Address | 3-8-3 Mizonokuchi, Takatsu-ku, Kawasaki, 213-8507, Japan |
| TEL | +81-44-844-3333 |
| Homepage URL | |
| YASUDAIC@aol.com | |
| Sponsor | |
| Institute | 19 gauge EUS-FNA for GSMT group |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We can exactly predict the recurrence risk of GISTs before surgical therapy. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019212 |